Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous dexmedetomidine plus midazolam for preoperative sedation in children undergoing laparoscopic surgery
ChiCTR-IPR-17012331Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and midazolam in preoperative anxiety, postoperative delirium (POD) and postoperative pain (2 arms), sponsored by Tongji Hospital. Primary endpoints: Sedation score, Postoperative delirium and 1 more. Started Aug 2017; status: recruiting.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
preoperative anxietypostoperative delirium (POD)postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-17012331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012331.